Literature DB >> 1728363

Variables correlated with the risk of lymph node metastasis in early rectal cancer.

J T Brodsky1, G K Richard, A M Cohen, B D Minsky.   

Abstract

To ascertain the risk of lymph node metastasis (LNM) from early rectal cancer, the authors retrospectively analyzed 154 patients with pT1 or pT2 rectal cancer treated by radical resection. Gross and microscopic pathologic characteristics of the primary tumor were examined as predictors of LNM. Comparisons were done by Fisher's test; significance was defined as a P value of less than 0.05. The incidence of LNM for T1 and T2 tumors was 3 of 26 (12%) and 28 of 128 (22%), respectively. LNM occurred significantly less often in well-differentiated cancers (0 of 12.0%). The incidence of LNM for T1/T2 tumors without lymphatic vessel invasion (LVI) or blood vessel invasion (BVI) (20 of 119, 17%) was significantly less than that for T1/T2 tumors with LVI or BVI (10 of 32, 31%). None of the T1 tumors without LVI or BVI had LNM. There was a trend toward decreased LNM for sessile nonulcerated tumors compared with nonpolypoid, exophytic, or ulcerated lesions (P = 0.06). Tumor size and colloid histologic characteristics were not significant predictive features for LNM. The data suggest that local excision alone is adequate for well-differentiated or moderately differentiated T1 rectal cancer in the absence of LVI or BVI and for well-differentiated T2 tumors. Radical resection or local excision combined with pelvic radiation therapy may be more appropriate for the remainder of early cancers.

Entities:  

Mesh:

Year:  1992        PMID: 1728363     DOI: 10.1002/1097-0142(19920115)69:2<322::aid-cncr2820690208>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  47 in total

1.  Depth of tumor invasion independently predicts lymph node metastasis in T2 rectal cancer.

Authors:  Pei-Rong Ding; Xin An; Yun Cao; Xiao-Jun Wu; Li-Ren Li; Gong Chen; Zhen-Hai Lu; Yu-Jing Fang; De-Sen Wan; Zhi-Zhong Pan
Journal:  J Gastrointest Surg       Date:  2010-10-05       Impact factor: 3.452

Review 2.  Treatment of stage II-III rectal cancer patients.

Authors:  Miranda B Kim; Theodore S Hong; Jennifer Y Wo
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

Review 3.  Challenges in the management of stage II colon cancer.

Authors:  Efrat Dotan; Steven J Cohen
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

4.  Local treatment for rectal cancer.

Authors:  Daniel P Geisler
Journal:  Clin Colon Rectal Surg       Date:  2007-08

5.  Lymphovascular invasion in colorectal cancer: an interobserver variability study.

Authors:  Elizabeth I Harris; David N Lewin; Hanlin L Wang; Gregory Y Lauwers; Amitabh Srivastava; Yu Shyr; Bashar Shakhtour; Frank Revetta; Mary K Washington
Journal:  Am J Surg Pathol       Date:  2008-12       Impact factor: 6.394

6.  Radical and local excisional methods of sphincter-sparing surgery after high-dose radiation for cancer of the distal 3 cm of the rectum.

Authors:  J P Bannon; G J Marks; M Mohiuddin; J Rakinic; N Z Jian; D Nagle
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

7.  Local management of rectal neoplasia.

Authors:  John Touzios; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2008-11

8.  Role of tumor size in the pre-operative management of rectal cancer patients.

Authors:  Inti Zlobec; Parham Minoo; Eva Karamitopoulou; George Peros; Efstratios S Patsouris; Frank Lehmann; Alessandro Lugli
Journal:  BMC Gastroenterol       Date:  2010-06-15       Impact factor: 3.067

9.  Local Excision vs. Radical Resection in T1-2 Rectal Carcinoma: Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data.

Authors:  L J Hazard; D C Shrieve; B Sklow; L Pappas; K M Boucher
Journal:  Gastrointest Cancer Res       Date:  2009-05

10.  The Factors Effecting Lymphovascular Invasion in Adenocarcinoma of the Colon and Rectum.

Authors:  Ali Aktekin; Selvinaz Özkara; Günay Gürleyik; Mehmet Odabaşi; Tolga Müftüoğlu; Abdullah Sağlam
Journal:  Indian J Surg       Date:  2013-01-26       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.